Thrombectomy for ischemic stroke · a broad range of ischemic stroke patients with large vessel...
24
Thrombectomy for ischemic stroke Prof Bruce Campbell Consultant Neurologist and Head of Stroke Royal Melbourne Hospital Professorial Fellow, University of Melbourne [email protected]
Transcript of Thrombectomy for ischemic stroke · a broad range of ischemic stroke patients with large vessel...
Thrombectomyforischemicstroke
ProfBruceCampbell
ConsultantNeurologistandHeadofStrokeRoyalMelbourneHospital
ProfessorialFellow,[email protected]
Disclosures Financialdisclosures–none
Off-labeluseoftenecteplaseforischaemicstroke
Learningobjectives Understandtheevidencebehindthrombectomyeligibility– siteofvesselocclusion– age– severity– time
Understandimagingstrategiesandtheprognosticsignificanceofischemiccorevolume
UnderstandtheroleofIVthrombolysisbeforethrombectomy– 0-4.5hrversus>4.5h
UnderstandthecriticalimportanceofSystemsofcareinmaximisingpatientoutcomes
Keymessages Endovascularthrombectomy(EVT)profoundlyreducesdisabilityin
abroadrangeofischemicstrokepatientswithlargevesselocclusion0-6hafterstrokeonset
EVTalsobenefitsselectedpatientswithfavorableperfusionimagingupto24hafterstrokeonset
CurrentlyEVTiscombinedwithIVthrombolysisineligiblepatients(withongoingtrialstestingEVTaloneinpatientspresentingdirectlytoEVTcenters)
Fastertreatmentisthemosteffectivewaytoimprovepatientoutcomes–streamlinetransfersandminimizere-imaging
Largevesselocclusion-thrombolysisvsthrombectomy
Thrombolysisonly
Thrombectomyonly
Thrombolysis&Thrombectomy
*“LVO”definitionmaychangewithdeviceimprovements
**plannedtrialstoaddIVlysistothrombectomy>4.5hr
>70%-noreperfusiontherapysuper-mild,established,verylate
largevesselocclusion(LVO) 15%ofallstrokebut 39%ofacutelypresentingstroke responsiblefor62%ofdependencyand
96%ofmortality(MalhotraFrontNeurol2017)
IVthrombolysishaslimitedefficacy
NewEngJMed2015: 5Positiverandomizedtrials 2Editorials Faster,betterreperfusion MoreImaging
Whichsitesofvesselocclusion?
ICAandM1–benefit tandemdisease(cervical+intracranial)–benefit ?M2 lesscommon,highlyvariableanatomy
smaller,moretortuous,lessaccessible
lessterritoryatrisk
greaterresponsetoIVthrombolysis
HERMESmeta-analysis=larger/dominant/moreproximalM2withhigherNIHSSbenefit–needtoindividualizedecision
M3/4,ACA,PCA-?? Basilar–excludedfrommosttrials,BEST20%benefit“astreated”,
BASICSRCTongoing.timewindow:?24hrfromlastknownwellvs~8hrfromonsetofcoma
ICA M1
?M2
not M3/4?
GoyaletalLancet2016
Agelimits?
AgeisprognosticAgedoesnotmodifytreatmenteffect
Severitylimits?
GoyaletalLancet2016
NIHSSisprognosticNIHSSdoesnotmodifytreatmenteffectUncertaintyinverymild(NIHSS0-5)àENDOLOWtrial
Thrombectomy– stilltimecritical
FransenJAMANeurology2016
MRCLEANselection(CTAocclusion)withsuccessfulreperfusion
Thrombectomy– stilltimecritical
7.3hrs
2.3 2.5 2.9
3.4 4.2
5.5 8.6
NNTs
SaverJAMA2016
Forevery4mindelayafterreachingemergency1in100patientswillhaveincreaseddisability
IschemicPenumbra–thereasonwecanimproveoutcomeafterischaemicstroke
Astrup,Symon1977
CTperfusion–diagnosisandprognosis
DelayedTTP/Tmax=collateralterritory
timeAreaundercurve≈0
conc
entr
atio
n
timeArea=CBV
TTP
conc
entr
atio
n
CBVLowCBV
=likelyirreversiblydamaged
CBF TTP
DiffusionMRI
AutomatedCTperfusionprocessing
“Howmuchbloodsupply”(severelyreduced≈dead)
relCBF<30%ofnormalbrainCampbelletalStroke2011
*timetoreperf&greyvswhitematter
“Howdelayedisthebloodsupply”(severelydelayed≈atrisk)
iSchemaViewRAPIDversion4.7
NogueiraNEJM2017
ordinalNNT2.0mRS0-2:49%vs13%,p<0.000184%mTICI2b/3SICH5.6%vs3.0%,p=0.50
ordinalNNT2.1
mRS0-245%vs17%,p<0.000176%mTICI2b/3SICH6.5%vs4.4%,p=0.75
AlbersNEJM2018
DAWNeligibilityeffectinDEFUSE3
AlbersetalNEJM2018
DEFUSE3criteria simpler ~60%morepatientseligible
Noreductionintreatmenteffectwithinage,NIHSSorcorevolumesincluded
i.e.6-24hrwithICA/M1and<70mLcoreàthrombectomy
DAW
Ne
ligib
le
no
tDAW
Ne
ligib
le
Istimestillbrain?
Overallstrokepopulationareverytimesensitive–stillneedtogoasfastaspossible
Theproportionofpatientswhoremaineligiblebyimagingcriteriadecreasesovertime(~50%ofLVOinthe6-24hrtimewindowbasedonDEFUSE3screening)
However,ifanindividualpatientisunavoidablydelayedinpresentationANDimagingisstillfavorablethentheyarelikelytobenefitfromreperfusion
Yes!
advancedimagingisnotjustabout“excluding”patients includingmorepatients
– mildNIHSSbutsignificantperfusionabnormality– late/unknowntime– “lowASPECTS”butonlymoderatevolumeNCCTchanges– clinically“marginal”butgoodimaging
AND diagnosticbenefits
– whenpatientspresentthefirstquestionis“isitstroke”– variablelevelsofexperienceonground,in-hours,after-hours,telemedicine– improvedNCCTinterpretationwhenyouknowwheretoscrutinize– LVOmaybechronic,partial,asymptomatic–perfusioncanhelp
AND Maybeinfuturewewillhavenon-reperfusion-basedtherapies…
– glyburide,NA1etcmightbenefitfromimagingtotargetthosenotlikelytodowelljustwithreperfusion
ImpactofCorevolume,AgeandTime(imagingtoreperfusion)onfunctionaloutcomeinpatientssuccessfullyreperfused
0 20 40 60 80 100
Age (years)
40
50
60
70
80
90 Imag
ing to
repe
rfusio
n (min)
50
100
150
200
250
% m
RS 0-2
0
20
40
60
80
100
Age (years)
40
50
60
70
80
90 Imag
ing to
repe
rfusio
n (min)
50
100
150
200
250
% m
RS 0-2
0
20
40
60
80
100
10mlcoremRS0-2 100mLcoremRS0-2
Age (years)
40
50
60
70
80
90 Imag
ing to
repe
rfusio
n (min)
50
100
150
200
250
% m
RS 0-30
20
40
60
80
100
100mLcoremRS0-3
For0-6hourpatientsdon’texcludepurelyonbasisofcorevolume:Balancecorevolumeandlocation,expectedtimetoreperfusion,pre-morbidstatus&toleranceofdisabilityifknown CampbelletalLancetNeurology2019
AllthepositiveRCTsadministeredalteplasetoalleligiblepatients…anditdoeshaveaneffect:
Ifeligibleforbothtreatmentsshouldwestillgivethrombolysisbeforethrombectomy?
IV-IAbridging DirectIA
potentialbenefitiffailure/delayinendovascularprocedure
potentialreductioninsymptomaticintracerebral(andsystemic)hemorrhage
potentialbenefitindissolvingdistalembolicfragmentsofthrombus/multi-territoryemboli
potentialreductionindistalmigration/fragmentationofthrombus“outofreach”priortoendovascularprocedure
potentialforpre-endovascularreperfusion savecostofalteplase/tenecteplase
Intervention Alteplase Standardcare
FinalReperfusionTICI2b/3[AngioCorelabdetermined]
77% --- ---
mAOL2-3(at2-8hCTA)[CTCorelabdetermined]
--- 37% 7%
GoyaletalESCAPE,NEJM2015
Meta-analysisofobservationaldata
MistryStroke2017
NBmostly“direct”patientswerelysis-ineligiblepatientsintendedforthrombectomywhorecanalizepriorwerenotincluded…
mRS0-2
DEATH
Recanwith≤2devicepasses
Recanalization
?thrombolysisfacilitatesthrombectomyevenifreperfusionnotachievedpriortoprocedure
SystemsofCare–TimeisBrain!
ConclusionsRapidreperfusionremainstheproventreatmentparadigminstroke Currentlythrombolysis+thrombectomyifeligibleforboth(DIRECTtrialsongoing)
ThrombectomyforICA,M1,tandem,basilar,selectedM2occlusions “Good”premorbidfunction Noageorclinicalseveritylimits 0-6h:broadimagingcriteria6-24h:DEFUSE3imagingselection<70mLcore CTperfusionisdiagnosticandcharacterizesirreversiblyinjuredcore/collaterals
-veryhelpfulforprognosisinanytimewindow Simplydeliveringthrombolysis&thrombectomyfasterandincreasingaccessto
appropriatepatientsisessentialtomaximizeeffectiveness–focusonsystemsofcare
~
